HMCIB SPAC 3 (KQ:226340) — Market Cap & Net Worth
Market Cap & Net Worth: HMCIB SPAC 3 (226340)
HMCIB SPAC 3 (KQ:226340) has a market capitalization of $48.90 Million (₩72.16 Billion) as of July 14, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #21988 globally and #1316 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HMCIB SPAC 3's stock price ₩1720.00 by its total outstanding shares 41952400 (41.95 Million). See HMCIB SPAC 3 capital spending ratio to understand how much of operating cash flow is reinvested back into capital assets.
HMCIB SPAC 3 Market Cap History: 2015 to 2026
HMCIB SPAC 3's market capitalization history from 2015 to 2026. Data shows change from $56.29 Million to $48.90 Million (-1.52% CAGR).
Index Memberships
HMCIB SPAC 3 is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$224.31 Billion | 0.02% | #613 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$224.31 Billion | 0.02% | #613 of 1384 |
Weight: HMCIB SPAC 3's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
HMCIB SPAC 3 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HMCIB SPAC 3's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
HMCIB SPAC 3's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $56.72 Million | $23.63 Billion | $116.97 Million | 0.00x | 0.48x |
| 2018 | $57.00 Million | $29.23 Billion | $313.44 Million | 0.00x | 0.18x |
| 2019 | $108.32 Million | $47.02 Billion | $5.03 Billion | 0.00x | 0.02x |
| 2020 | $66.67 Million | $36.05 Billion | -$1.92 Billion | 0.00x | N/A |
| 2021 | $63.26 Million | $53.81 Billion | -$3.98 Billion | 0.00x | N/A |
| 2022 | $47.19 Million | $60.72 Billion | $2.00 Billion | 0.00x | 0.02x |
| 2023 | $64.11 Million | $72.91 Billion | -$724.79 Million | 0.00x | N/A |
Competitor Companies of 226340 by Market Capitalization
Companies near HMCIB SPAC 3 in the global market cap rankings as of July 14, 2026.
Key companies related to HMCIB SPAC 3 by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #44 globally with a market cap of $346.70 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #95 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- LOréal S.A. (PA:OR): Ranked #113 globally with a market cap of $188.75 Billion USD ( €161.45 Billion EUR).
- Unilever PLC (NASDAQ:UNLYD): Ranked #199 globally with a market cap of $120.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #44 | Procter & Gamble Company | NYSE:PG | $346.70 Billion | $148.37 |
| #95 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #113 | LOréal S.A. | PA:OR | $188.75 Billion | €381.80 |
| #199 | Unilever PLC | NASDAQ:UNLYD | $120.76 Billion | $55.38 |
HMCIB SPAC 3 Historical Marketcap From 2015 to 2026
Between 2015 and today, HMCIB SPAC 3's market cap moved from $56.29 Million to $ 48.90 Million, with a yearly change of -1.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩48.90 Million | +17.97% |
| 2025 | ₩41.45 Million | +6.42% |
| 2024 | ₩38.95 Million | -39.25% |
| 2023 | ₩64.11 Million | +35.84% |
| 2022 | ₩47.19 Million | -25.39% |
| 2021 | ₩63.26 Million | -5.12% |
| 2020 | ₩66.67 Million | -38.45% |
| 2019 | ₩108.32 Million | +90.02% |
| 2018 | ₩57.00 Million | +0.50% |
| 2017 | ₩56.72 Million | +0.50% |
| 2016 | ₩56.43 Million | +0.25% |
| 2015 | ₩56.29 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 14th, 2026 the market cap of HMCIB SPAC 3 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $48.90 Million USD |
| MoneyControl | $48.90 Million USD |
| MarketWatch | $48.90 Million USD |
| marketcap.company | $48.90 Million USD |
| Reuters | $48.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About HMCIB SPAC 3
Bonne Co., Ltd. develops and supplies cosmetics in South Korea. The company offers skin care products, including whitening, wrinkle and pimple treatment, stem-cell peptide, and nano peptide products; and sun care products comprising fluids, creams, emulsions, etc. It also provides hair and body care products; makeup products, such as foundation, powder, compact, loose powder, BB cream, eye liner,… Read more